Detection of ALK Gene Rearrangement in Non-small Cell Lung Cancer A Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization with Correlation of ALK Protein Expression

被引:123
作者
Kim, Hyojin [2 ]
Yoo, Seol-Bong [2 ]
Choe, Ji-Young [2 ]
Paik, Jin Ho [1 ]
Xu, Xianhua [1 ]
Nitta, Hiroaki [3 ]
Zhang, Wenjun [4 ]
Grogan, Thomas M. [3 ,5 ]
Lee, Choon-Taek [6 ]
Jheon, Sanghoon [7 ]
Chung, Jin-Haeng [1 ,2 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam 463707, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea
[3] Ventana Med Syst Inc, Med Innovat, Tucson, AZ USA
[4] Ventana Med Syst Inc, Mol Assay Dev, Tucson, AZ USA
[5] Univ Arizona, Coll Med, Dept Pathol, Tucson, AZ 85721 USA
[6] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
[7] Seoul Natl Univ, Bundang Hosp, Dept Thorac Surg, Songnam 463707, South Korea
关键词
Lung cancer; ALK; Fluorescence in situ hybridization; Chromogenic in situ hybridization; GROWTH-FACTOR RECEPTOR; COPY NUMBER DETECTION; EML4-ALK FUSION GENE; AMPLIFICATION; MULTICENTER; CARCINOMAS; EGFR;
D O I
10.1097/JTO.0b013e31821cfc73
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Accurate determination of ALK rearrangement is important in lung cancer patients, especially in determining their eligibility for crizotinib therapy. Fluorescence in situ hybridization (FISH) has been regarded as the gold standard method for detecting ALK rearrangement. However, FISH requires a fluorescence microscope, and the signals are labile and rapidly fade over time. This study evaluates the concordance between ALK gene rearrangement in non-small cell lung cancer assessed by ALK FISH and a newly developed ALK chromogenic in situ hybridization (CISH) and correlates the results with ALK protein expression assessed by immunohistochemistry. Methods: A total of 465 formalin-fixed, paraffin-embedded non-small cell lung cancer samples were analyzed by ALK FISH (Path-Vysion, Vysis, Abbott) and ALK CISH. For comparison, all specimens were stained by immunohistochemistry (clone 5A4, Novocastra) and interobserver reproducibility was assessed. Results: We found that agreement between the pathologists on the CISH-determined ALK status was achieved in 449 patients (96.6%), and ALK rearrangement was identified in 18 patients (4.0%) in CISH method. Among these cases, 443 cases (95.3%) had results matching the corresponding FISH results: 17 rearranged, 425 wild types, and 1 discordant case. There was high concordance in the assessment of ALK gene rearrangement between FISH and CISH techniques (kappa = 0.92) and between observers (kappa = 0.97). In addition, there was high concordance in the ALK gene status and ALK protein expression between CISH and IHC tests (kappa = 0.82). Conclusions: CISH is a highly reproducible and practical method to detect ALK gene rearrangement and correlated well with ALK protein expression. Here, we present a diagnostic algorithm (Chung's SNUBH ALK protocol) to detect lung cancer with ALK rearrangements using IHC, FISH and CISH. Because CISH allows a concurrent analysis of histological features of the tumors and gene rearrangement, it appears to be a useful method in determining ALK gene rearrangement.
引用
收藏
页码:1359 / 1366
页数:8
相关论文
共 20 条
[1]   Chromogenic In Situ Hybridization A Multicenter Study Comparing Silver In Situ Hybridization With FISH [J].
Bartlett, J. M. S. ;
Campbell, Fiona M. ;
Ibrahim, Merdol ;
Wencyk, Peter ;
Ellis, Ian ;
Kay, Elaine ;
Connolly, Yvonne ;
O'Grady, Anthony ;
Di Palma, Silvana ;
Starczynski, Jane ;
Morgan, John M. ;
Jasani, Bharat ;
Miller, Keith .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (04) :514-520
[2]   The 2004 World Health Organization classification of lung tumors [J].
Beasley, MB ;
Brambilla, E ;
Travis, WD .
SEMINARS IN ROENTGENOLOGY, 2005, 40 (02) :90-97
[3]   Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas [J].
Boland, Jennifer M. ;
Erdogan, Sibel ;
Vasmatzis, George ;
Yang, Ping ;
Tillmans, Lori S. ;
Johnson, Michele R. Erickson ;
Wang, Xiaoke ;
Peterson, Lisa M. ;
Halling, Kevin C. ;
Oliveira, Andre M. ;
Aubry, Marie Christine ;
Yi, Eunhee S. .
HUMAN PATHOLOGY, 2009, 40 (08) :1152-1158
[4]   Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens [J].
Garcia-Caballero, Tomas ;
Grabau, Dorthe ;
Green, Andrew R. ;
Gregory, John ;
Schad, Arno ;
Kohlwes, Elke ;
Ellis, Ian O. ;
Watts, Sarah ;
Mollerup, Jens .
HISTOPATHOLOGY, 2010, 56 (04) :472-480
[5]   EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset [J].
Inamura, Kentaro ;
Takeuchi, Kengo ;
Togashi, Yuki ;
Hatano, Satoko ;
Ninomiya, Hironori ;
Motoi, Noriko ;
Mun, Ming-yon ;
Sakao, Yukinori ;
Okumura, Sakae ;
Nakagawa, Ken ;
Soda, Manabu ;
Choi, Young Lim ;
Mano, Hiroyuki ;
Ishikawa, Yuichi .
MODERN PATHOLOGY, 2009, 22 (04) :508-515
[6]   Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer [J].
Kwak, Eunice L. ;
Bang, Yung-Jue ;
Camidge, D. Ross ;
Shaw, Alice T. ;
Solomon, Benjamin ;
Maki, Robert G. ;
Ou, Sai-Hong I. ;
Dezube, Bruce J. ;
Jaenne, Pasi A. ;
Costa, Daniel B. ;
Varella-Garcia, Marileila ;
Kim, Woo-Ho ;
Lynch, Thomas J. ;
Fidias, Panos ;
Stubbs, Hannah ;
Engelman, Jeffrey A. ;
Sequist, Lecia V. ;
Tan, WeiWei ;
Gandhi, Leena ;
Mino-Kenudson, Mari ;
Wei, Greg C. ;
Shreeve, S. Martin ;
Ratain, Mark J. ;
Settleman, Jeffrey ;
Christensen, James G. ;
Haber, Daniel A. ;
Wilner, Keith ;
Salgia, Ravi ;
Shapiro, Geoffrey I. ;
Clark, Jeffrey W. ;
Iafrate, A. John .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18) :1693-1703
[7]   Chromogenic and fluorescent in situ hybridization in breast cancer [J].
Lambros, Maryou B. K. ;
Natrajan, Rachael ;
Reis-Filho, Jorge S. .
HUMAN PATHOLOGY, 2007, 38 (08) :1105-1122
[8]   Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study [J].
Lee, Hyun Ju ;
Xu, Xianhua ;
Choe, Gheeyoung ;
Chung, Doo Hyun ;
Seo, Jeong-Wook ;
Lee, Jae Ho ;
Lee, Choon-Taek ;
Jheon, Sanghoon ;
Sung, Sook-Whan ;
Chung, Jin-Haeng .
LUNG CANCER, 2010, 68 (03) :375-382
[9]   Automated brightfield break-apart in situ hybridization (ba-ISH) application: ALK and MALT1 genes as models [J].
Nitta, Hiroaki ;
Zhang, Wenjun ;
Kelly, Brian D. ;
Miller, Melanie ;
Pestic-Dragovich, Lidija ;
Bieniarz, Christopher ;
Vasicek, Thomas J. ;
Marafioti, Teresa ;
Rimsza, Lisa ;
Grogan, Thomas M. .
METHODS, 2010, 52 (04) :352-358
[10]   Screening of Anaplastic Lymphoma Kinase Rearrangement by Immunohistochemistry in Non-small Cell Lung Cancer Correlation with Fluorescence In Situ Hybridization [J].
Paik, Jin Ho ;
Choe, Gheeyoung ;
Kim, Hyojin ;
Choe, Ji-Young ;
Lee, Hyun Ju ;
Lee, Choon-Taek ;
Lee, Jong Seok ;
Jheon, Sanghoon ;
Chung, Jin-Haeng .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) :466-472